COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,225 Articles (22,733 medRxiv, 8,492 bioRxiv)

Most recent first Previous |  Page 2536: Articles 25351-25360  | Next

Combination of Antibody based rapid diagnostic tests used in an algorithm may improve their performance in SARS CoV-2 diagnosis.
Kushemererwa, G. E., Kayongo, I., Semanda, P., Nansumba, H., Namulindwa, C., Tadeo, I., Nyegenye, W., Kiyaga, C., Ogwok, P. A., Nabadda, S., Ssewanyana, I.
10.1101/2020.06.26.20140806 — Posted: 2020-06-29
Genomic epidemiology of SARS-CoV-2 in Colombia
Laiton-Donato, k., Villabona Arenas, C. J., Usme Ciro, J. A., Franco Munoz, C., Alvarez-Diaz, D. A., Villabona-Arenas, L. S., Echeverria-Londono, S., Franco-Sierra, N. D., Cucunuba, Z. M., Florez-Sanchez, A. C., Ferro, C., Ajami, N. J., Walteros, D. M., Prieto-Alvarado, F. E., Duran-Camacho, C. A., Ospina-Martinez, M. L., Mercado-Reyes, M. M.
10.1101/2020.06.26.20135715 — Posted: 2020-06-29 Discussion: Onsite
Macropahge expression and prognostic significance of the long pentraxin PTX3 in COVID-19
Brunetta, E., Folci, M., Bottazzi, B., De Santis, M., Protti, A., Mapelli, S., Leone, R., My, I., Bacci, M., Zanon, V., Spata, G., Gianatti, A., Sironi, M., Angelini, C., Garlanda, C., Ciccarelli, M., Cecconi, M., Mantovani, A.
10.1101/2020.06.26.20139923 — Posted: 2020-06-29 Discussion: Onsite
Estimation of COVID-19 dynamics in the different states of the United States using Time-Series Clustering
Rojas, I., Rojas, F., Valenzuela, O.
10.1101/2020.06.29.20142364 — Posted: 2020-06-29
Beta regression with spatio-temporal effects as a tool for hospital impact analysis of initial phase epidemics: the case of COVID-19 in Spain
Jannes, G., Barreal, J.
10.1101/2020.06.27.20141614 — Posted: 2020-06-29
Diagnostic technology for COVID-19: comparative evaluation of antigen and serology-based SARS-CoV-2 immunoassays, and contact tracing solutions for potential use as at-home products
Jorfi, M., Luo, N. M., Hazra, A., Herisson, F., Miller, G., Toombs, J. A., Walt, D. R., Bonato, P., Ahmad, R., COVID-19 Direct-to-Consumer Task Force Investigators
10.1101/2020.06.25.20140236 — Posted: 2020-06-29
Silk fabric as a protective barrier for personal protective equipment and as a functional material for face coverings during the COVID-19 pandemic
Parlin, A. F., Stratton, S. M., Culley, T. M., Guerra, P. A.
10.1101/2020.06.25.20136424 — Posted: 2020-06-29 Discussion: Onsite
Cirrhosis and COVID-19: a fatal case of viral peritonitis and disseminated infection
Passarelli, V. C., Perosa, A., Luna, L., Conte, D., Nascimento, O., Ota-Arakaki, J., Bellei, N.
10.1101/2020.06.25.20139998 — Posted: 2020-06-29
Efficacy and Safety of Remdesivir for COVID-19 Treatment: An Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
Zhu, Y., Teng, Z., Yang, L., Xu, S., Liu, J., Teng, Y., Hao, Q., Zhao, D., Li, X., Lu, S., Zeng, Y.
10.1101/2020.06.22.20136531 — Posted: 2020-06-29
SUPERSPREADING AS A REGULAR FACTOR OF THE COVID-19 PANDEMIC
Dimaschko, J.
10.1101/2020.06.29.20138008 — Posted: 2020-06-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).